NonSegmental Vitiligo Clinical Trials

9 clinical trials for NonSegmental Vitiligo across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Zasocitinib in Adults With Nonsegmental Vitiligo — RECRUITING · PHASE2
• A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo — RECRUITING · PHASE3
• A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo — RECRUITING · PHASE3
• Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo — RECRUITING · PHASE2
• A multicenter, randomized, double-blind, placebo-controlled, dose-ranging Phase IIb study to assess the efficacy and safety of GIA632 in adult participants with non-segmental vitiligo followed by an extension period — TERMINATED · PHASE2
• B7981080 - A PHASE 3 RANDOMIZED, DOUBLE-BLIND, 52-WEEK PLACEBOCONTROLLED MULTI-CENTER STUDY WITH A DOUBLE-BLIND 52-WEEK EXTENSION PERIOD WITH RANDOMIZED DOSE UP/DOSE DOWN TITRATION INVESTIGATING THE EFFICACY, SAFETY, AND TOLERABILITY OF RITLECITINIB IN ADULT PARTICIPANTS WITH NONSEGMENTAL VITILIGO — TERMINATED · PHASE3
• A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2) — ACTIVE_NOT_RECRUITING · PHASE3
• A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1) — ACTIVE_NOT_RECRUITING · PHASE3
• A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo — COMPLETED · PHASE2

Refine this search